Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 4 of 4 for “"RARG"”.

  1. The Role of Cleavage and Polyadenylation Spcific Factor 6 (CPSF6) in Hematopoiesis

    … I contributed to related exploratory studies on RARG fusion genes reported in APLL. My efforts laid the foundation for future work on RARG fusions in leukemia.</p>

    uthsc Repository record for The Role of Cleavage and Polyadenylation Spcific Factor 6 (CPSF6) in Hematopoiesis (opens in a new tab)

  2. The genetics of anthracycline-induced cardiotoxicity in cancer patients

    … NCF4 (rs1883112): RAC2 (rs13058338) and RARG (rs2229774), and tested for correlation with clinical status and cardiac injury. Finally, a corollary study was conducted on a subset of patients in an attempt to determine whether cardiac biomarkers may be more sensitive measures of …

    cape-town Repository record for The genetics of anthracycline-induced cardiotoxicity in cancer patients (opens in a new tab)

  3. The role of retinoic acid in glioma growth control

    … glioma. Retinoic acid receptor genes RARA, RARB, RARG, retinoid X receptor genes RXRA, RXRB, RXRG, transcriptional co-activator genes EP300, NCOA1, NCOA2, transcriptional co-repressor genes HDAC2, NCOR1, and NRPI1 are all significantly lower in high grade glioma with an increase in the expression …

    cork Repository record for The role of retinoic acid in glioma growth control (opens in a new tab)

  4. Evaluating The Therapeutic Efficacy of Restoring Wild-Type P53 Activity In P53-Mutant Tumors

    <p>The p53 transcription factor is the most frequently altered in human cancers usually via missense mutations that undermine its transcriptional activity. Clinically, <em>TP53</em> mutations have been shown to be remarkably predictive of refractoriness to treatment, resulting in poor outcome. …

    uthsc Repository record for Evaluating The Therapeutic Efficacy of Restoring Wild-Type P53 Activity In P53-Mutant Tumors (opens in a new tab)